Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mamoru Harada

Showing results (71-80 of 103) with videos related to

Pageof 11
Sort By:
Cancers|August 29, 2024
Therapeutic Senolysis of Axitinib-Induced Senescent Human Lung Cancer CellsHitoshi Kotani, Wei Han, Yuichi Iida, et al.
Oncology Reports|April 22, 2008
Identification of EphB6 variant-derived epitope peptides recognized by cytotoxic T-lymphocytes from HLA-A24+ malignant glioma patientsMingyue Jin, Yoshihiro Komohara, Shigeki Shichijo, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 15, 2005
Prostatic acid phosphatase as a target molecule in specific immunotherapy for patients with nonprostate adenocarcinomaYi Wang, Mamoru Harada, Hirohisa Yano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 21, 2006
Antitumor effects of systemic and local immunization with a CTL-directed peptide in combination with a local injection of OK-432Takeharu Ono, Mamoru Harada, Akira Yamada, et al.
International Journal of Oncology|October 8, 2005
Identification of human papillomavirus 16-E6 protein-derived peptides with the potential to generate cytotoxic T-lymphocytes toward human leukocyte antigen-A24+ cervical cancerMiho Hara, Satoko Matsueda, Mayumi Tamura, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 29, 2010
Provision of continuous maturation signaling to dendritic cells by RIG-I-stimulating cytosolic RNA synthesis of Sendai virusShinji Okano, Yoshikazu Yonemitsu, Ken Shirabe, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 7, 2007
New peptide vaccine candidates for epithelial cancer patients with HLA-A3 supertype allelesSatoko Matsueda, Hiroko Takedatsu, Tetsuro Sasada, et al.
Japanese Journal of Cancer Research : Gann|February 22, 2002
Serine proteinase inhibitor 9 can be recognized by cytotoxic T lymphocytes of epithelial cancer patientsKoji Tanaka, Nanae Harashima, Fumihiko Niiya, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 10, 2007
Cyclophosphamide-using nonmyeloablative allogeneic cell therapy against renal cancer with a reduced risk of graft-versus-host diseaseMasatoshi Eto, Masahiko Harano, Katsunori Tatsugami, et al.
Oncology Research|May 24, 2007
Combination therapy of personalized peptide vaccination and low-dose estramustine phosphate for metastatic hormone refractory prostate cancer patients: an analysis of prognostic factors in the treatmentMasanori Noguchi, Takashi Mine, Akira Yamada, et al.
Pageof 11

Showing results (71-80 of 103) with videos related to

Sort By:
Pageof 11
Cancers|August 29, 2024
Therapeutic Senolysis of Axitinib-Induced Senescent Human Lung Cancer CellsHitoshi Kotani, Wei Han, Yuichi Iida, et al.
Oncology Reports|April 22, 2008
Identification of EphB6 variant-derived epitope peptides recognized by cytotoxic T-lymphocytes from HLA-A24+ malignant glioma patientsMingyue Jin, Yoshihiro Komohara, Shigeki Shichijo, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 15, 2005
Prostatic acid phosphatase as a target molecule in specific immunotherapy for patients with nonprostate adenocarcinomaYi Wang, Mamoru Harada, Hirohisa Yano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 21, 2006
Antitumor effects of systemic and local immunization with a CTL-directed peptide in combination with a local injection of OK-432Takeharu Ono, Mamoru Harada, Akira Yamada, et al.
International Journal of Oncology|October 8, 2005
Identification of human papillomavirus 16-E6 protein-derived peptides with the potential to generate cytotoxic T-lymphocytes toward human leukocyte antigen-A24+ cervical cancerMiho Hara, Satoko Matsueda, Mayumi Tamura, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 29, 2010
Provision of continuous maturation signaling to dendritic cells by RIG-I-stimulating cytosolic RNA synthesis of Sendai virusShinji Okano, Yoshikazu Yonemitsu, Ken Shirabe, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 7, 2007
New peptide vaccine candidates for epithelial cancer patients with HLA-A3 supertype allelesSatoko Matsueda, Hiroko Takedatsu, Tetsuro Sasada, et al.
Japanese Journal of Cancer Research : Gann|February 22, 2002
Serine proteinase inhibitor 9 can be recognized by cytotoxic T lymphocytes of epithelial cancer patientsKoji Tanaka, Nanae Harashima, Fumihiko Niiya, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 10, 2007
Cyclophosphamide-using nonmyeloablative allogeneic cell therapy against renal cancer with a reduced risk of graft-versus-host diseaseMasatoshi Eto, Masahiko Harano, Katsunori Tatsugami, et al.
Oncology Research|May 24, 2007
Combination therapy of personalized peptide vaccination and low-dose estramustine phosphate for metastatic hormone refractory prostate cancer patients: an analysis of prognostic factors in the treatmentMasanori Noguchi, Takashi Mine, Akira Yamada, et al.
Pageof 11